Search

Author/Creator Nakamura, S

2. 40OBiomarker analyses of Asian women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) receiving ribociclib (RIB) + endocrine therapy (ET). (25th November 2018)

Authors:
Yap, Y S; Masuda, N; Ito, Y; Ishikawa, T; Kim, S J; Aruga, T; Toyama, T; Saeki, T; Yamanaka, T; Saito, M; Watanabe, J; Takahashi, M; Nakamura, S; Inoue, K; Suarez-Vizcarra, J; He, W; Solovieff, N; Su, F; Chiu, J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 42PRibociclib (RIB) + endocrine therapy (ET) in Japanese women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC). (25th November 2018)

Authors:
Masuda, N; Noguchi, S; Ishikawa, T; Aruga, T; Kim, S J; Toyama, T; Saeki, T; Saito, M; Yamanaka, T; Watanabe, J; Nakamura, S; Takahashi, M; Inoue, K; Gounaris, I; Han, Y; Samant, T S; Gazdoiu, M; Ito, Y
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. A next-generation liquid xenon observatory for dark matter and neutrino physics. (1st January 2023)

Authors:
Aalbers, J; AbdusSalam, S S; Abe, K; Aerne, V; Agostini, F; Ahmed Maouloud, S; Akerib, D S; Akimov, D Y; Akshat, J; Al Musalhi, A K; Alder, F; Alsum, S K; Althueser, L; Amarasinghe, C S; Amaro, F D; Ames, A; Anderson, T J; Andrieu, B; Angelides, N; Angelino, E
Journal:
Journal of physics
Issue:
Volume 50:Number 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗